Welcome to our dedicated page for QT Imaging Holdings news (Ticker: QTIH), a resource for investors and traders seeking the latest updates and insights on QT Imaging Holdings stock.
QT Imaging Holdings, Inc. (OTCQB: QTIH) is a medical device company focused on body imaging systems that use low frequency sound waves, with a particular emphasis on breast imaging. The company’s news flow centers on the commercialization of its QTI Breast Acoustic CT™ scanner, a breast imaging system described as radiation-free, contrast-free, and compression-free, as well as on the evolution of its cloud-enabled imaging platform.
On this page, readers can follow company announcements about scanner shipments and revenue milestones, including updates that link revenue growth to the number of QTI Breast Acoustic CT™ scanners shipped. QT Imaging’s press releases also provide details on distribution agreements with partners such as NXC Imaging, Inc., a subsidiary of Canon Medical Systems USA, and Gulf Medical Co. in Saudi Arabia, which are referenced in connection with shipment plans and revenue outlooks.
Investors and healthcare professionals can review financial result announcements, where QT Imaging discusses quarterly revenue, year-over-year growth, and non-GAAP measures such as EBITDA and Adjusted EBITDA, along with commentary on its financial position and capital structure. News items also cover capital markets activities, including a private placement (PIPE) financing and a 3:1 reverse stock split, as well as the company’s stated intention to pursue a relisting on the Nasdaq Capital Market.
Beyond financial and corporate updates, QT Imaging issues news about technology collaborations and clinical outreach. Examples include a strategic collaboration with Intelerad Medical Systems to deploy cloud-based PACS across its research and commercial networks, and participation in the RSNA annual meeting with seminars on quantitative transmission imaging and live demonstrations of its FDA-cleared Breast Acoustic CT™ scanner. Visitors can use this news feed to track how QT Imaging is advancing its imaging technology, expanding distribution, and developing its cloud SaaS and AI/ML capabilities over time.
QT Imaging (OTCQB: QTIH) announced on October 20, 2025 that it has applied to relist on the Nasdaq Capital Market and approved a 3:1 reverse stock split to meet Nasdaq's $4.00 minimum bid requirement. The board fixed the 3:1 ratio on October 17, 2025 and the split becomes effective at 4:01 p.m. EDT on October 23, 2025, with split-adjusted trading resuming on the OTCQB on October 24, 2025 under the symbol QTIH. Share count will decrease from 35,671,332 to 11,890,444 shares before rounding; after rounding for fractional shares the company expects at least ~11,890,612 shares outstanding. New CUSIP: 746962307. CST is the exchange agent; eligible holders need not take action.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, has secured an $18 million PIPE financing through a private placement. The company is selling approximately 12.12 million shares at $1.50 per share, along with equivalent warrants exercisable at the same price for five years.
The financing, anchored by Sio Capital Management, will be used to repay $5 million of senior secured term loan to Lynrock Lake Master Fund LP, expand U.S. and global market activities, and deploy the QTI Cloud Platform. Additionally, the company is preparing to initiate its NASDAQ relisting process.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, has appointed Jay Jennings as its new Chief Financial Officer, effective September 2, 2025. Jennings, who brings nearly 30 years of executive management experience, will replace current CFO Anastas Budagov.
Jennings' impressive track record includes leading two go-public transactions, managing finance teams of up to 100 employees, and involvement in 12 business acquisitions. He previously served as Acting CEO and CFO at UpHealth, Inc., and held executive roles at eHealth, Inc. and MetaCreation Corporation. The appointment aligns with QT Imaging's strategic goals of evolving into a scalable imaging platform and pursuing a Nasdaq uplisting.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, has secured $5.0 million in additional financing through an amended senior secured term loan from Lynrock Lake Master Fund LP. The company utilized these funds to fully repurchase warrants held by Yorkville (YA II PN, Ltd.), which consisted of 15,000,000 shares at $0.40 per share.
CEO Dr. Raluca Dinu expressed confidence in the company's future outlook, emphasizing that the current stock valuation presents an attractive investment opportunity to enhance long-term shareholder value.
QT Imaging Holdings (OTCQB: QTIH) has secured an exclusive distribution agreement with Gulf Medical Co. (GMC) for Saudi Arabia. The agreement covers the distribution of QTI's FDA-cleared Breast Acoustic CT™ scanner and QTI Cloud Platform subscriptions.
The deal mandates minimum orders of 5 scanners per quarter from Q1 2026 through 2028, totaling 60 scanners and generating over $33 million in revenue. The technology is particularly relevant for Saudi Arabia's market, where there's a higher prevalence of BRCA mutations and breast cancer cases among women aged 40-59 years.
The QTI Breast Acoustic CT™ scanner provides non-invasive 3D breast imaging without compression, contrast, or radiation. The company is also developing a QTI Cloud Platform with AI-driven tools for automated findings classification and second-read decision support.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, held its first Annual Stockholder Meeting on August 19, 2025. Stockholders approved three key items: the election of Daniel Dickson and James Greene as Class I directors until 2028, the appointment of BPM LLP as independent auditors for FY2025, and authorization for a reverse stock split with a ratio between 2:1 and 20:1, to be determined by the Board.
QT Imaging Holdings (OTCQB: QTIH) reported strong Q2 2025 financial results, with revenue reaching $3.7 million, representing 113% year-over-year and 31% sequential growth. The company achieved a 50% gross margin and shipped eight QT Breast Acoustic CT™ scanners during Q2, plus two more in July.
Key developments include the launch of the new QTI Cloud Platform, strengthening their transformation into a precision imaging AI company, and amendments to warrant agreements with Lynrock Lake and Yorkville. The company maintains its 2025 revenue guidance of $18 million (40 scanners) and projects $27 million for 2026 (60 scanners).
QT Imaging is pursuing a Nasdaq uplisting and recently raised $700,000 through PIPE investments. The company ended Q2 with $2.0 million in cash, which increased to $4.3 million by August 6, 2025.
[ "Revenue grew 113% year-over-year to $3.7 million in Q2 2025", "Strong gross margin of 50% maintained", "Successfully shipped 8 scanners in Q2 plus 2 more in July 2025", "Cash position improved from $2.0M to $4.3M post-collections", "Secured $700,000 in new PIPE investments", "Operating expenses reduced by 7% year-over-year", "Launch of new QTI Cloud Platform creating potential recurring revenue stream" ]QT Imaging Holdings (OTCQB: QTIH) has launched QTviewer 2.8, an enhanced version of its medical imaging software that complements their FDA-cleared QTI Breast Acoustic CT scanner. The new version introduces significant improvements including stateless DICOM viewing, real-time lesion doubling time analysis, and advanced RGB visualization modes.
The software update features improved multi-series comparison capabilities, optimized viewport layouts, and secure enterprise license management. Notable enhancements include automatic image type recognition and streamlined workflow processes. This release follows the recent introduction of image reconstruction software v4.4.0, which significantly reduced QTscan processing time.
QT Imaging Holdings (OTCQB: QTIH) has announced two key leadership appointments to strengthen its medical and clinical capabilities. Dr. Elaine Iuanow, a board-certified breast radiologist with over 20 years of experience, joins as Chief Medical Officer, while Kim Du becomes Senior Director of Clinical Operations.
The appointments support QTI's expansion of clinical studies and development of AI-driven lesion classification and second-read decision support tools for its FDA-cleared QTI Breast Acoustic CT™ scanner. The technology aims to provide an alternative to MRI, particularly beneficial for the 50% of U.S. women aged 40-74 with dense breast tissue.
The company is focusing on transforming into a precision imaging AI company, with plans to conduct multi-center clinical trials studying their technology as an MRI alternative for high-risk women and breast cancer management.
QT Imaging Holdings (OTCQB: QTIH), a medical device company focused on innovative body imaging systems, has announced its 2025 Annual Meeting of Stockholders. The meeting will be held virtually on August 19, 2025, at 1:00 p.m. EDT.
Stockholders of record as of July 16, 2025 will be eligible to vote at the meeting. Detailed information about the virtual meeting access and participation instructions will be provided in the upcoming proxy statement and made available on the company's investor relations website.